C242T polymorphism of the NADPH oxidase p22PHOX gene and its association with endothelial dysfunction in asymptomatic individuals with essential systemic hypertension

Rafiq,Adnan; Aslam,Khursheed; Malik,Rouf; Afroze,Dil

doi:10.3892/mmr.2014.1992

C242T polymorphism of the NADPH oxidase p22PHOX gene and its association with endothelial dysfunction in asymptomatic individuals with essential systemic hypertension

Authors:
- Adnan Rafiq
- Khursheed Aslam
- Rouf Malik
- Dil Afroze
View Affiliations

Affiliations: Gastroenterology Division, ASCOMS & Hospital, Jammu, Jammu and Kashmir 190011, India, Department of Cardiology, Sher‑i‑Kashmir Institute of Medical Sciences, Srinagar 190011, India, Department of Immunology and Molecular Medicine, Sher‑i‑Kashmir Institute of Medical Sciences, Srinagar 190011, India
Published online on: February 26, 2014 https://doi.org/10.3892/mmr.2014.1992
Pages: 1857-1862

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vascular oxidative stress is an important factor in hypertension‑associated vascular damage and is mediated by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation. The C242T polymorphism at the p22PHOX gene affects binding of p22PHOX to heme, leading to variants of NADPH oxidase that produce different levels of reactive oxygen species (ROS). Specific variations in ROS are associated with an altered risk of developing cardiovascular disease. In the present study, 140 permanent Kashmiri‑resident individuals were recruited (75 with essential systemic hypertension and 65 normotensive controls). Endothelial function was assessed non‑invasively using high‑resolution ultrasonography of the brachial artery. Endothelium‑dependent vasoreactivity was expressed in terms of flow‑mediated dilation. The TT genotype was identified in 2% of hypertensive and 7% of normotensive individuals. Frequency of the T‑allele was not observed as significantly different between hypertensive and normotensive individuals (P=0.24; OR=0.4; 95% CI, 0.07‑2.2). Blood pressure or the prevalence of hypertension did not vary between C242T p22PHOX genotypes or in the presence or absence of the T‑allele.

View Figures

View References

1	Zeiher AM, Drexler H, Wollschlager H, et al: Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation. 84:1984–1992. 1991. View Article : Google Scholar : PubMed/NCBI
2	Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801–809. 1993. View Article : Google Scholar : PubMed/NCBI
3	Davignon J and Ganz P: Role of endothelial dysfunction in atherosclerosis. Circulation. 109:27–32. 2004. View Article : Google Scholar
4	Landmesser U, Horni B and Drexler H: Endothelial function. A critical determinant in atherosclerosis? Circulation. 19:27–33. 2004.
5	Ross R: Atherosclerosis - an inflammation disease. N Engl J Med. 340:115–125. 1999. View Article : Google Scholar
6	Altman R: Risk factors in coronary atherosclerosis athero-inflammation: the meeting point. Thrombosis J. 1:4–10. 2003. View Article : Google Scholar : PubMed/NCBI
7	Schächinger V and Zeiher AM: Atherogenesis - recent insights into basic mechanisms and their clinical impact. Nephrol Dial Transplant. 17:2055–2064. 2002.PubMed/NCBI
8	Ohara Y, Peterson TE, Sayegh HS, et al: Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation. 92:898–903. 1995. View Article : Google Scholar : PubMed/NCBI
9	Harrison DG: Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 100:2153–2157. 1997. View Article : Google Scholar : PubMed/NCBI
10	Brandes RP, Barton M, Philippens KM, et al: Endothelial-derived superoxide anions in pig coronary arteries: evidence from lucigenin chemiluminescence and historical techniques. J Physiol. 500:331–342. 1997. View Article : Google Scholar : PubMed/NCBI
11	Warnholtz A, Nickenig G, Schulz E, et al: Increased NADH- oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the rennin-angiotensin system. Circulation. 99:2027–2033. 1999. View Article : Google Scholar : PubMed/NCBI
12	Rajagopalan S, Kurz S, Münzel T, et al: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest. 97:1916–1923. 1996. View Article : Google Scholar : PubMed/NCBI
13	Guzik TJ, West NEJ, Black E, et al: Vascular superoxide production by NAD(P)H oxidase association with endothelial dysfunction and clinical risk factors. Circ Res. 86:85–90. 2000. View Article : Google Scholar
14	Rueckschloss U, Galle J, Holtz J, et al: Induction of NAD(P) oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation. 104:1767–1772. 2001. View Article : Google Scholar
15	Sumimoto H, Hata K, Mizuki K, et al: Assembly and activation of the phagocyte NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of p47PHOX with p22PHOX is required for activation of the NADPH oxidase. J Biol Chem. 271:22152–22158. 1996. View Article : Google Scholar : PubMed/NCBI
16	Ushio-Fukai M, Zafari AM, Fukai T, et al: p22PHOX is a critical component of the superoxide generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 271:23317–23321. 1996. View Article : Google Scholar
17	Sundaresan M, Yu ZX, Ferrans VJ, Irani K and Finkel T: Requirement for generation of H₂O₂ for platelet derived growth factor signal transduction. Science. 270:296–299. 1995.
18	Zalba G, Jose GS, Moreno MU, et al: NADPH oxidase mediated oxidative stress: genetic studies of p22PHOXgene in hypertension. Antioxid Redox Signal. 7:1327–1336. 2005. View Article : Google Scholar : PubMed/NCBI
19	Wyche KE, Wang SS, Griendling KK, et al: C242T CYBA polymorphism of NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension. 43:1246–1251. 2004. View Article : Google Scholar : PubMed/NCBI
20	Guzik TJ, West NE, Black DE, et al: Functional effects of the C242T polymorphism in the NAD(P)H oxidase p22PHOX gene on vascular superoxide production in atherosclerosis. Circulation. 102:1744–1747. 2000. View Article : Google Scholar : PubMed/NCBI
21	Laursen JB, Rajagopalan S, Galis Z, et al: Role of superoxide in angiotensin II induced but not catecholamine induced hypertension. Circulation. 95:588–593. 1997. View Article : Google Scholar : PubMed/NCBI
22	Mollnau H, Wendt M, Szocs K, et al: Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMPsignaling. Circ Res. 90:58–65. 2002. View Article : Google Scholar : PubMed/NCBI
23	Fukui T, Ishizaka N, Rajagopalan S, et al: p22PHOX mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res. 80:45–51. 1997. View Article : Google Scholar : PubMed/NCBI
24	Paravincini TM and Touyz RM: Redox signaling in hypertension. Cardiovasc Res. 71:247–258. 2006. View Article : Google Scholar
25	Suzuki H, Swei A, Zweifach BW, et al: In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidinemicrofluorography. Hypertension. 25:1083–1089. 1995. View Article : Google Scholar : PubMed/NCBI
26	Nakazono K, Watanabe N, Matsuno K, et al: Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA. 88:10045–10085. 1991. View Article : Google Scholar : PubMed/NCBI
27	Higashi Y, Sasaki S, Nakagawa K, et al: Endothelial function and oxidative stress by products in human hypertension. Hypertension. 41:1096–1101. 2003. View Article : Google Scholar
28	Redon J, Oliva MR, Tormos C, et al: Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension. 41:1091–1101. 2003. View Article : Google Scholar : PubMed/NCBI
29	Li L, Fink GD, Watts SW, et al: Endothelin I increases vascular superoxide via endothelin (A)-NAD(P)H oxidase pathway in low rennin hypertension. Circulation. 107:1053–1058. 2003. View Article : Google Scholar : PubMed/NCBI
30	Beswick RA, Dorrance AM, Leite R, et al: NADH/NADPH oxidase and enhanced superoxide production in the mineralo- corticoid hypertensive rat. Hypertension. 38:1107–1111. 2001. View Article : Google Scholar : PubMed/NCBI
31	Pettit AI, Wong RK, Lee V, et al: Increased free radical production in hypertension due to increased expression of NADPH oxidase subunit p22PHOX in lymphoblast cell lines. J Hypertens. 20:677–683. 2002. View Article : Google Scholar : PubMed/NCBI
32	Fortuno A, Olivan S, Beloqui O, et al: Association of increased phagocytic NAD(P)H oxidase dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens. 22:2169–2175. 2004. View Article : Google Scholar
33	Zalba G, Beaumont FJ, San Jose G, et al: Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension. 35:1055–1061. 2000. View Article : Google Scholar : PubMed/NCBI
34	Castejon AM, Bracero J, Hoffman IS, et al: NAD(P)H oxidase p22PHOXgene C242T polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens. 20:772–779. 2006. View Article : Google Scholar : PubMed/NCBI
35	Nasti S, Balbi M, Fabbi P, et al: CYBA polymorphism associated with oxidative stress in Italian patients with early onset of coronary artery disease. Ital Heart J. 3:S52–S54. 2002.
36	Moreno MU, Jose GS, Fortuno A, et al: The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension. J Hypertens. 24:1299–1306. 2006. View Article : Google Scholar : PubMed/NCBI
37	Inoue N, Kawashima S, Kanazawa K, et al: Polymorphism of the NADH/NADPH oxidase p22PHOX gene in patients with coronary artery disease. Circulation. 97:135–137. 1998. View Article : Google Scholar : PubMed/NCBI
38	Fan M, Kähönen M, Rontu R, et al: The p22PHOX C242T gene polymorphism is associated with a reduced risk of angiographically verified coronary artery disease in a high-risk Finnish Caucasian population. The Finnish cardiovascular study. Am Heart J. 152:538–542. 2006. View Article : Google Scholar
39	Shimo-Nakanishi Y, Hasebe T, Suzuki A, et al: Functional effects of NAD(P)H oxidase p22PHOX C242T mutation in human leukocytes and association with thrombotic cerebral infraction. Atherosclerosis. 175:109–115. 2004. View Article : Google Scholar : PubMed/NCBI
40	Ito D, Murata M, Watanabe K, et al: C242T polymorphism of NADPH oxidase p22PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke. 31:936–939. 2000. View Article : Google Scholar : PubMed/NCBI
41	Cai H, Duarte N, Wilcken DE, et al: NADH/NADPH oxidase p22PHOX C242T polymorphism and coronary artery disease in the Australian population. Eur J Clin Invest. 29:744–748. 1999. View Article : Google Scholar : PubMed/NCBI
42	Cahilly C, Ballantyne CM, Lim DS, et al: A variant of p22PHOX, involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res. 86:391–395. 2000. View Article : Google Scholar : PubMed/NCBI
43	Hyashi Okano R, Yamasaki Y, Kajimoto Y, et al: Association of NAD(P)H oxidase p22PHOX gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care. 26:458–463. 2003.PubMed/NCBI
44	Nasti S, Spallarossa P, Aitieri P, et al: C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians. Dis Markers. 22:167–173. 2006. View Article : Google Scholar : PubMed/NCBI
45	Schachinger V, Britten MB, Dimmeler S, et al: NADH/NADPH oxidase p22PHOX gene polymorphism is associated with improved coronary endothelial vasodilator function. Eur Heart J. 22:96–101. 2001. View Article : Google Scholar : PubMed/NCBI
46	Schneider MP, Hilgers KF, Huang Y, et al: The C242T p22PHOX polymorphism and endothelium-dependent vasodilation in patients with hypercholesterolemia. Clin Sci. 105:97–103. 2003. View Article : Google Scholar : PubMed/NCBI
47	Li A, Prasad A, Mincemoyer R, et al: Relationship of the C242T p22PHOX gene polymorphism to angiographic coronary artery disease and endothelial function. Am J Med Genet. 86:57–61. 1999. View Article : Google Scholar : PubMed/NCBI
48	Levey AS, Bosch JP, Lewis JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 130:461–470. 1999. View Article : Google Scholar
49	Inoguchi T, Li P, Umeda F, et al: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NADPH oxidase in cultured vascular cells. Diabetes. 49:1939–1945. 2000. View Article : Google Scholar
50	Hink U, Li H, Mollnau H, et al: Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 88:E14–E22. 2001. View Article : Google Scholar : PubMed/NCBI